Gene: SPINK2
Official Full Name: serine peptidase inhibitor Kazal type 2provided by HGNC
Gene Summary: This gene encodes a member of the family of serine protease inhibitors of the Kazal type (SPINK). The encoded protein acts as a trypsin and acrosin inhibitor in the genital tract and is localized in the spermatozoa. The protein has been associated with the progression of lymphomas. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13788 | SPINK2 Knockout cell line (HCT 116) | Human | SPINK2 | 1:2~1:4 | Negative | Online Inquiry |
KO13789 | SPINK2 Knockout cell line (HEK293) | Human | SPINK2 | 1:3~1:6 | Negative | Online Inquiry |
SPINK2 Gene Knockout Cell Lines are genetically modified mammalian cell lines specifically engineered to lack the expression of the SPINK2 gene. SPINK2 (Serine Peptidase Inhibitor, Kazal Type 2) plays a crucial role in various physiological processes, particularly in the regulation of serine proteases and the maintenance of tissue integrity. These knockout cell lines provide a valuable tool for researchers aiming to investigate the functional implications of SPINK2 depletion on cellular mechanisms, including apoptosis, inflammation, and cellular signaling pathways.
The key function of these cell lines lies in their ability to model the absence of SPINK2, enabling scientists to elucidate its role in disease contexts, particularly in conditions such as pancreatitis and cancer. By comparing the behavior of SPINK2 knockout cells with their wild-type counterparts, researchers can gain insights into the molecular pathways impacted by this gene, thereby advancing our understanding of its therapeutic potential. Moreover, the SPINK2 knockout model serves as an experimental platform for drug discovery and biomarker identification.
The scientific significance of SPINK2 Gene Knockout Cell Lines is underscored by their applications in both fundamental research and translational studies. These cell lines are invaluable for studies focusing on the pathological implications of serine protease dysregulation, especially in pancreatic disorders and related diseases. They facilitate targeted interventions and drug efficacy assessments, making them indispensable for both academic laboratories and pharmaceutical companies.
What sets SPINK2 Gene Knockout Cell Lines apart from other genetic models is their specificity and ease of use. The knockout process is streamlined, ensuring a reliable and reproducible model that aligns with the principles of gene editing technologies like CRISPR/Cas9. This unique offering allows researchers to save valuable time in their experiments and yield reproducible results that can accelerate discoveries.
For researchers and clinicians seeking to deepen their understanding of serine protease function or explore therapeutic avenues, SPINK2 Gene Knockout Cell Lines present a unique opportunity to improve experimental rigor and innovation. With our leading expertise in genetic engineering and a commitment to supporting scientific advancement, we provide robust and accessible biological tools designed to enhance your research capabilities.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.